The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro

Journal of Cell Science

Volumn 112, Issue 10, 1999, Pages 1599-1609

  Kräling, Birgit M ^a,b,d   Wiederschain, Dmitri G ^a,b   Boehm, Thomas ^a,b   Rehn, Marko ^c   Mulliken, John B ^a,b   Moses, Marsha A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF OULU   (Finland)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiogenesis; Basement membrane; Endothelium; Matrix metalloproteinase; Tissue inhibitor of matrix metalloproteinase

Indexed keywords

AMINOCAPROIC ACID; BUCLADESINE; COLLAGEN TYPE 4; COLLAGEN TYPE 8; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; HYDROCORTISONE; LAMININ; MATRIX METALLOPROTEINASE; PHENANTHROLINE; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANGIOGENESIS; ARTICLE; BIOASSAY; CAPILLARY BASEMENT MEMBRANE; CAPILLARY ENDOTHELIUM; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MICROVASCULARIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN CELL;

BASEMENT MEMBRANE; BUCLADESINE; CELL ADHESION; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; METALLOENDOPEPTIDASES; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UP-REGULATION;

EID: 0344780901     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Auerbach, W. and Auerbach, R. (1994). Angiogenesis inhibition: a review. Pharmacol. Ther. 63, 265-311.
2. Berger, T. S., Parandoosh, Z., Perry, B. W. and Stein, R. B. (1992). Interaction of glucocorticoid analogues with the human glucocorticoid receptor. J. Steroid. Biochem. Mol. Biol. 41, 733-738.
3. Brooks, P. C., Clark, R. A. and Cheresh, D. A. (1994a). Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569-571.
4. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld R. A., Hu, T., Klier, G. and Cheresh, D. A. (1994b). Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
5. Butt, E., van Bemmelen, M., Fisher, L., Walter, U. and Jastorff, B. (1990). Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′.5′-monophosphorothioates. FEBS Lett. 263, 47-50.
6. Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M. and Ingber, D. E. (1997). Geometric control of cell life and death. Science 276, 1425-1428.
7. Cornelius, L. A., Nehring, L. C., Roby, J. D., Parks, W. C. and Welgus, H. G. (1995). Human dermal microvascular endothelial cells produce matrix metalloproteinase in response to angiogenic factors and migration. J. Invest. Dermatol. 105, 170-176.
8. Crum, R., Szabo, S. and Folkman, J. (1985). A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230, 1375-1378.
9. Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A. and Bouck, N. P. (1997). CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138, 707-717.
10. DiPietro, L. A. (1997). Thrombospondin as a regulator of angiogenesis. EXS. 79, 295-314.
11. Fisher, C., Gilbertson-Beadling, S., Powers, E. A., Petzold, G., Poorman, R. and Mitchell, M. A. (1994). Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol. 162, 499-510.
12. Folkman, J. and Ingber, D. E. (1987). Angiostatic Steroids. Method of discovery and mechanism of action. Ann. Surg, 206, 374-383.
13. Gailit, J. and Clark, R. A. F. (1994). Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6, 717-725.
14. Goldman, P. S., Tran, V. K. and Goodman, R. H. (1997). The multifunctional role of the co-activator CBP in transcriptional activation. Recent Prog. Horm. Res. 52, 103-119.
15. Grant, D. S., Lelkes, P. l., Fukuda, K. and Kleinman, H. K. (1991). Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In vitro Cell. Dev. Biol. 27, 327-336.
16. Grant, D. S. and Kleinman, H. K. (1997). Regulation of capillary formation by laminin and other components of the extracellular matrix. EXS. 79, 317-333.
17. Grant, D. S., Tashiro, K., Segui-Real, B., Yamada, Y., Martin, G. R. and Kleinman, H. K. (1989). Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell. 58, 933-943.
18. Hanahan, D. (1997). Signaling vascular morphogenesis and maintenance. Science 277, 48-50.
19. Hanemaaijer, R., Koolwijk, P., Le Clercq, L., De Vree, W. J. and Van Hinsbergh, V. W. (1993). Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem. J. 296, 803-809.
20. Haralabopoulos, G. C., Grant, D. S., Kleinman, H. K., Lelkes, P. I., Papaioannou, S. P. and Maragoudakis, M. E. (1994). Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Lab. Invest. 71, 575-582.
21. Hobson, B. and Denekamp, J. (1984). Endothelial proliferation in tumours and normal tissues: continuous labeling studies. Br. J. Cancer 49, 405-413.
22. Ingber, D. (1991). Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J. Cell. Biochem. 47, 236-241.
23. Iruela-Arispe, M. L., Hasselaar, P. and Sage, H. (1991). Differential Expression of extracellular proteins is correlated with angiogenesis in vitro. Lab. Invest. 64, 174-186.
24. Iruela-Arispe, M. L., Porter, P., Bornstein, P. and Sage, E. H. (1996). Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J. Clin. Invest. 97, 403-412.
25. Johnson, M. D., Kim, H.-R. C., Chester, L., Tsao-Wu, G., Bouck, N. and Polverini, P. J. (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160, 194-202.
26. Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A. and Kaneko, M. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440.
27. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W. and Martin, G. R (1986). Basement membrane complexes with biological activities. Biochemistry 25, 312-318.
28. Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts J. M. and Ross, R. (1996). Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell 87, 1069-1078.
29. Kräling, B. M. and Bischoff, J. (1998). A simplified method for growth of human dermal microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors. In vitro Cell Dev. Biol. Anim. 33, 308-315.
30. Kubota, Y., Kleinman, H. K., Martin, G. S. and Lawley, T. J. (1988). Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107, 1589-1598.
31. Lawley, T. J. and Kubota, Y. (1989). Induction of morphologic differentiation of endothelial cells in culture. J. Invest. Dermatol. 93, 59S-61S.
32. Mignatti, P., Tsuboi, R., Robbins, E. and Rifkin, D. B. (1989). In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108, 671 -682.
33. Montesano, R., Mouron, P. and Orci, L. (1985). Vascular outgrowth from tissue expiants embedded in fibrin or collagen gels: a simple in vitro model of angiogenesis. Cell Biol. Int. Rep. 9, 869-875.
34. Moses, M. A., Sudhalter, J. and Langer, R. (1990). Identification of an inhibitor of neovascularization from cartilage. Science 248, 1408-1410.
35. Moses, M. A., Sudhalter, J. and Langer, R. (1992). Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes. J. Cell Biol. 119, 475-482.
36. Moses, M. A. (1997). The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 15, 180-189.
37. Mulliken, J. B. (1988). Vascular Birthmarks: Hemangiomas and Malformations (ed. A. E. Young). W. B. Saunders and Company, Philadelphia.
38. Munck, A., Mendel, D. B., Smith, L. I. and Orti, E. (1990). Glucocorticoid receptors and actions. Am. Rev. Respir. Dis. 141, S2-S10.
39. Muragaki, Y., Timmons, S., Griffith, C. M., Oh, S. P., Fadel, B., Quertermous, T. and Olsen, B. R. (1995). Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl. Acad. Sci. USA 92, 8763-8767.
40. Murphy, A. N., Unsworth, E. J. and Stetler-Stevenson, W. G. (1993) Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157, 351-358.
41. Murphy, G., Willenbrock, F., Crabbe, T., O'Shea, M., Ward, R., Atkinson, S., O'Connell, J. and Docherty, A. (1994). Regulation of matrix metalloproteinase activity. Ann. NY Acad. Sci. 732, 31-41.
42. Nagase, H. (1996). Matrix metalloproteinases. In Zinc Metalloproteases in Health and Disease (ed. N. M. Hooper), pp. 153-204. Taylor and Francis, London.
43. Nicosia, R. F. and Madri, J. A. (1987). The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am. J. Pathol. 128, 78-90.
44. Nicosia, R. F., Belser, P., Bonanno, E. and Diven, J. (1991). Regulation of angiogenesis in vitro by collagen metabolism. In vitro Cell, Dev. Biol. 27A, 961-966.
45. Nicosia, R. F., Bonanno, E. and Villaschi, S. (1992). Large-vessel endothelium switches to a microvascular phenotype during angiogenesis in collagen gel culture of rat aorta. Atherosclerosis 95, 191-199.
46. Oliver, M. H., Harrison, N. K., Bishop, J. E., Cole, P. J. and Laurent, G. J. (1989). A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 92, 513-518.
47. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olson, B. R. and Folkman, J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
48. Pepper, M. S., Montesano R., Mandriota, S. J., Orci, L. and Vassalli, J.-D. (1996). Angiogenesis: a paradigm for balanced extracellular proteolysis during migration and morphogenesis. Enzyme Protein 49, 138-162.
49. Peters, C. A., Freeman, M. R., Fernandez, C. A., Shephard, J., Wiederschain, D. G. and Moses, M. A. (1997). Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease. Am. J. Physiol. 272, R1960-R1965.
50. Ray, J. M. and Stetler-Stevenson, W. G. (1994). The role of matrix proteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062-2072.
51. Rehn, M. and Pihlajaniemi, T. (1994). Alpha 1 (XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc. Natl. Acad. Sci. USA 91, 4234-4238.
52. Risau, W. (1995). Differentiation of endothelium. FASEB J. 9, 926-933.
53. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
54. Saarela, J., Rehn, M., Oikarinen, A., Autio-Harmainen, H. and Pihlajaniemi, T. (1998). The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in man. Am. J. Pathol. 153, 611-626.
55. Takahashi, K., Mulliken, J. B., Kozakewich, H. P. W., Rogers, R. A., Folkman, J., and Ezekowitz, R. A. (1994). Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. Clin. Invest. 93, 2357-2364.
56. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J. and Bouck N. (1993). Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell biol. 122, 497-511.